Your Complete Guide to
Therapeutic Peptides

Ultra-long-acting basal insulin with 42-hour duration, marketed as Tresiba.

Long-acting basal insulin with albumin binding for extended duration, marketed as Levemir.

Rapid-acting insulin analog, marketed as Humalog, first rapid-acting analog approved.

Synthetic nootropic peptide that enhances memory, learning, and provides neuroprotection.

Long-acting PEGylated G-CSF for chemotherapy support, single dose per cycle.

Brand name for synthetic oxytocin used in obstetrics for labor induction and augmentation.

Short-acting human insulin for mealtime coverage, slower than analogs.

Recombinant human growth hormone for GH deficiency, multiple brands and indications.

Extended version of Argireline with enhanced muscle-relaxing and anti-wrinkle effects.

Anti-edema peptide that reduces puffiness, particularly effective for under-eye area.

Alternative name for PT-141 – see PT-141 entry for full details.

Neurotrophic peptide preparation derived from porcine brain with neuroprotective and cognitive-enhancing properties.

Recombinant version of HCG for fertility treatments, alternative to urinary HCG.

Modified version of Epithalon with C-terminal amidation for enhanced stability and potency.

Natural pineal gland extract from which Epithalon was synthesized, used for longevity in Russian research.

Anti-CGRP monoclonal antibody for migraine prevention, IV formulation.

Once-weekly formulation of exenatide for improved convenience in diabetes management.

Modified fragment of human growth hormone specifically for fat loss without other HGH effects.